Position in NVCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$935,034
-$205,146 QoQ
Shares Held
85,783
-2.7% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 30.794049525828793.ToString("F0")%
Shared 0.ToString("F0")%
None 69.2059504741712.ToString("F0")%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Focus Partners Wealth holds $477,561,093 across 32 Medical Devices names. NVCR ranks #15 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,520,912 | $258,822,035 | |
| 2 | GEHC |
GE HealthCare Technologies Inc.
|
894,358 | $63,660,402 | |
| 3 | SYK |
Stryker Corp
|
156,039 | $51,272,855 | |
| 4 | MDT |
Medtronic plc
|
433,122 | $37,530,021 | |
| 5 | BSX |
Boston Scientific Corp
|
411,492 | $25,821,123 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
136,313 | $12,325,421 | |
| 7 | ITGR |
Integer Holdings Corp
|
67,386 | $5,929,968 | |
| 8 | PODD |
Insulet Corp
|
20,760 | $4,356,278 |
All Filings in NVCR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $935,034 | 85,783 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,140,180 | 88,181 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $1,670,209 | 93,832 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,645,445 | 92,337 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $2,767,585 | 92,872 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,492,602 | 95,496 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,625,876 | 94,914 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,458,044 | 93,285 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $805,697 | 53,965 | Shares | Sole | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||